DD234417A5 - Verfahren zur herstellung von 1,3-disubstituerten 2-oxindoeln als analytische und entzuendungshemmende mittel - Google Patents
Verfahren zur herstellung von 1,3-disubstituerten 2-oxindoeln als analytische und entzuendungshemmende mittel Download PDFInfo
- Publication number
- DD234417A5 DD234417A5 DD85273087A DD27308785A DD234417A5 DD 234417 A5 DD234417 A5 DD 234417A5 DD 85273087 A DD85273087 A DD 85273087A DD 27308785 A DD27308785 A DD 27308785A DD 234417 A5 DD234417 A5 DD 234417A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- carbons
- alkyl
- oxindole
- formula
- thienyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57790384A | 1984-02-07 | 1984-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD234417A5 true DD234417A5 (de) | 1986-04-02 |
Family
ID=24310612
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD85273087A DD234417A5 (de) | 1984-02-07 | 1985-02-06 | Verfahren zur herstellung von 1,3-disubstituerten 2-oxindoeln als analytische und entzuendungshemmende mittel |
| DD86288635A DD244133A5 (de) | 1984-02-07 | 1986-04-01 | Verfahren zur herstellung von substituierten 2-oxindolen als analgetische und entzuendungshemmende mittel |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD86288635A DD244133A5 (de) | 1984-02-07 | 1986-04-01 | Verfahren zur herstellung von substituierten 2-oxindolen als analgetische und entzuendungshemmende mittel |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4658037A (pt) |
| JP (1) | JPS60248669A (pt) |
| KR (2) | KR880000433B1 (pt) |
| BG (3) | BG43865A3 (pt) |
| CS (1) | CS252480B2 (pt) |
| DD (2) | DD234417A5 (pt) |
| HU (1) | HU194166B (pt) |
| IN (1) | IN163263B (pt) |
| MW (1) | MW185A1 (pt) |
| PL (3) | PL145230B1 (pt) |
| RO (2) | RO93218B (pt) |
| YU (3) | YU43866B (pt) |
| ZA (1) | ZA85888B (pt) |
| ZM (1) | ZM785A1 (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4721712A (en) * | 1984-06-12 | 1988-01-26 | Pfizer Inc. | 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents |
| US4808601A (en) * | 1984-09-19 | 1989-02-28 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| US4752609A (en) * | 1985-06-20 | 1988-06-21 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| HU215112B (hu) * | 1989-01-10 | 1998-12-28 | Pfizer Inc. | Eljárás gyulladáscsökkentő 1-heteroaril-3-acil-2-oxindol-származékok előállítására |
| US5086186A (en) * | 1989-05-25 | 1992-02-04 | Pfizer Inc. | N-trichloroacetyl-2-oxindole-1-carboxamides |
| US4952703A (en) * | 1989-05-25 | 1990-08-28 | Pfizer Inc. | Intermediates for making 2-oxindole-1-carboxamides |
| US5298522A (en) * | 1993-01-22 | 1994-03-29 | Pfizer Inc. | 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio |
| US5607959A (en) * | 1993-02-09 | 1997-03-04 | Pfizer Inc. | Oxindole 1-[N-(alkoxycarbonyl) ] carboxamides and 1-(N-carboxamido) carboxamides as antiinflammatory agents |
| AU2002322720B2 (en) | 2001-07-25 | 2008-11-13 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| JP2008539047A (ja) | 2005-04-28 | 2008-11-13 | プロテウス バイオメディカル インコーポレイテッド | ファーマインフォーマティックスシステム |
| JP2010503710A (ja) | 2006-09-18 | 2010-02-04 | ラプトール ファーマシューティカル インコーポレイテッド | 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置 |
| JP2009040790A (ja) * | 2008-08-29 | 2009-02-26 | Ube Ind Ltd | ５−フルオロオキシインドールの製造法 |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| ES2942923T3 (es) | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| CN103570604B (zh) * | 2012-07-21 | 2015-10-07 | 重庆圣华曦药业股份有限公司 | 齐拉西酮中间体的合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3462450A (en) * | 1966-06-29 | 1969-08-19 | Merck & Co Inc | Chemical compounds |
| GB1158532A (en) * | 1967-01-05 | 1969-07-16 | Centre Nat Rech Scient | 2-Oxoindoline-3-Carboxylic Acids and Esters thereof |
| US3631177A (en) * | 1967-04-18 | 1971-12-28 | Smith Kline French Lab | 3-phenacyl-2-oxoindolines |
| US3519592A (en) * | 1967-04-18 | 1970-07-07 | Smithkline Corp | Indole compounds |
| BE714717A (pt) * | 1967-05-12 | 1968-09-30 | ||
| FR7337M (pt) * | 1968-01-11 | 1969-10-13 | ||
| BE756447A (fr) * | 1969-10-15 | 1971-03-22 | Pfizer | Oxindolecarboxamides |
| US3749731A (en) * | 1971-07-08 | 1973-07-31 | Warner Lambert Co | 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide |
| US3975531A (en) * | 1973-10-02 | 1976-08-17 | A. H. Robins Company, Incorporated | 4-(5- And 7-)benzoylindolin-2-ones and pharmaceutical uses thereof |
| US4221716A (en) * | 1979-02-16 | 1980-09-09 | A. H. Robins Company, Inc. | Intermediate and process for the preparation of 7-acylindolin-2-ones |
-
1985
- 1985-01-22 IN IN42/DEL/85A patent/IN163263B/en unknown
- 1985-02-04 RO RO121802A patent/RO93218B/ro unknown
- 1985-02-04 RO RO85117533A patent/RO90621A2/ro unknown
- 1985-02-05 CS CS85785A patent/CS252480B2/cs unknown
- 1985-02-05 ZM ZM7/85A patent/ZM785A1/xx unknown
- 1985-02-05 KR KR1019850000714A patent/KR880000433B1/ko not_active IP Right Cessation
- 1985-02-05 MW MW1/85A patent/MW185A1/xx unknown
- 1985-02-06 YU YU180/85A patent/YU43866B/xx unknown
- 1985-02-06 ZA ZA85888A patent/ZA85888B/xx unknown
- 1985-02-06 DD DD85273087A patent/DD234417A5/de not_active IP Right Cessation
- 1985-02-06 BG BG8572172A patent/BG43865A3/xx unknown
- 1985-02-06 BG BG8568717A patent/BG40963A3/xx unknown
- 1985-02-06 HU HU854686A patent/HU194166B/hu unknown
- 1985-02-06 JP JP60020163A patent/JPS60248669A/ja active Granted
- 1985-02-06 BG BG8572170A patent/BG44204A3/xx unknown
- 1985-02-07 PL PL1985255466A patent/PL145230B1/pl unknown
- 1985-02-07 PL PL1985251869A patent/PL145196B1/pl unknown
- 1985-02-07 PL PL1985255465A patent/PL145310B1/pl unknown
- 1985-12-30 US US06/814,719 patent/US4658037A/en not_active Expired - Lifetime
-
1986
- 1986-04-01 DD DD86288635A patent/DD244133A5/de not_active IP Right Cessation
-
1987
- 1987-04-10 KR KR1019870003430A patent/KR880000434B1/ko not_active IP Right Cessation
- 1987-07-09 YU YU129087A patent/YU46320B/sh unknown
- 1987-10-30 YU YU1981/87A patent/YU44062B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| YU198187A (en) | 1988-10-31 |
| PL145310B1 (en) | 1988-09-30 |
| KR850005824A (ko) | 1985-09-26 |
| RO93218B (ro) | 1988-01-01 |
| CS78585A2 (en) | 1987-01-15 |
| ZA85888B (en) | 1986-09-24 |
| BG44204A3 (en) | 1988-10-14 |
| YU129087A (en) | 1988-02-29 |
| RO90621A2 (ro) | 1986-12-10 |
| JPS60248669A (ja) | 1985-12-09 |
| RO93218A (ro) | 1987-12-31 |
| KR880000434B1 (ko) | 1988-03-24 |
| PL145196B1 (en) | 1988-08-31 |
| YU18085A (en) | 1988-04-30 |
| CS252480B2 (en) | 1987-09-17 |
| YU44062B (en) | 1990-02-28 |
| PL251869A1 (en) | 1985-12-17 |
| JPH0413340B2 (pt) | 1992-03-09 |
| US4658037A (en) | 1987-04-14 |
| KR880000433B1 (ko) | 1988-03-24 |
| PL145230B1 (en) | 1988-08-31 |
| DD244133A5 (de) | 1987-03-25 |
| BG43865A3 (en) | 1988-08-15 |
| HU194166B (en) | 1988-01-28 |
| MW185A1 (en) | 1986-04-09 |
| IN163263B (pt) | 1988-08-27 |
| YU43866B (en) | 1989-12-31 |
| ZM785A1 (en) | 1985-08-22 |
| YU46320B (sh) | 1993-05-28 |
| BG40963A3 (en) | 1987-03-14 |
| PL255465A1 (en) | 1986-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0763037B1 (de) | [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE | |
| EP0164860B1 (en) | N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents | |
| EP0156603B1 (en) | 3-substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents | |
| DD234417A5 (de) | Verfahren zur herstellung von 1,3-disubstituerten 2-oxindoeln als analytische und entzuendungshemmende mittel | |
| EP0175551B1 (en) | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds | |
| US4721712A (en) | 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents | |
| EP0804437B1 (de) | [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE | |
| EP0763036B1 (de) | [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE | |
| AT376976B (de) | Verfahren zur herstellung von neuen 5-substituierten oxazolidin-2,4-dionen und ihren salzen | |
| DD251971A5 (de) | Verfahren zur herstellung einer pharmazeutisch aktiven oxindol-verbindung | |
| DE2461802A1 (de) | Pyrazinderivate | |
| EP0153818B1 (en) | 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents | |
| DD232039A5 (de) | Verfahren zur herstellung einer 2-oxinidol-1-carboxamid-verbindung | |
| CH633288A5 (de) | Verfahren zur herstellung von neuen heterocyclylaminoderivaten. | |
| DE2241027A1 (de) | Verfahren zur herstellung neuer heterocyclischer verbindungen | |
| US4808601A (en) | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds | |
| US4752609A (en) | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds | |
| DD254001A5 (de) | Verfahren zur herstellung von heterocyclischen oxophtalazinylessigsaeuren | |
| DD232916A5 (de) | Verfahren zur herstellung von 2-oxindol-1-carboxamiden oder pharmazeutisch akzeptabler salze hiervon | |
| KR870000289B1 (ko) | 2-옥스인돌 유도체의 제조방법 | |
| CA1289556C (en) | 1- or 3-monosubstituted 2-oxindole compound intermediates useful for the production of analgesic and anti-inflammatory agents | |
| CA1255657A (en) | 1,3-disubstituted 2-oxindoles as analgesic and anti- inflammatory agents | |
| DD232265A5 (de) | Verfahren zur herstellung von 2-oxindol-1-carboxamiden und zwischenstufen dafuer | |
| IE850288L (en) | Analgesic oxindoles. | |
| DE19757627A1 (de) | Azulenderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzung, die diese Verbindungen enthält |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NPV | Change in the person, the name or the address of the representative (addendum to changes before extension act) | ||
| ENJ | Ceased due to non-payment of renewal fee |